Abstract
To select the relevant evidence on risk factors for intracranial hemorrhage (ICH) after
thrombolysis with alteplase in patients with acute ischemic stroke (AIS) at home and abroad, and summarize the
best evidence to provide a reference for reducing the risk of ICH after thrombolysis in patients with AIS. Meth?
ods: Systematically search all evidence related to risk factors for ICH after alteplase thrombolysis in patients
with AIS from domestic and foreign databases and official websites of relevant associations, including relevant
guidelines, best clinical practice, expert consensus, summary of relevant evidence, systematic reviews, and various standards. The search time limit is January 1, 2010 - December 31, 2022. Then analyze and summarize the
search results. Results: A total of 14 articles were included, including 6 guidelines, 1 expert consensus, 4 systematic reviews, and 3 scientific statements. Through the analysis of the 14 related literature according to the scientific steps, it was concluded that there are 8 factors related to ICH after alteplase thrombolysis in patients with
AIS: time window, hypertension, hyperglycemia, admission National Institutes of Health Stroke Scale (NIHSS)
score, atrial fibrillation, neutrophil percentage before thrombolysis, large area infarction, early ischemic changes
on head CT before thrombolysis. Conclusion: This study summarizes the best evidence on risk factors related
to ICH after alteplase thrombolysis in patients with AIS, providing an evidence-based basis for reducing its incidence.
Key words
acute ischemic stroke
Cite this article
Download Citations
Summary of the Optimal Evidence of Risk Factors for Intracranial Hemorrhage after Throm?
bolysis with Alteplase in Patients with Acute Ischemic Stroke[J]. Neural Injury and Functional Reconstruction. 2023, 18(12): 744-748
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}